NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Signatures announced today that it has signed agreements to raise A$14 million ($10.6 million) through the sale of 29.8 million new shares to institutional investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.